Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
6
pubmed:dateCreated
2008-11-17
pubmed:abstractText
We studied the impact of heparin-binding epidermal growth factor-like growth factor (HB-EGF) on inflammation-driven hepatocarcinogenesis.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Dec
pubmed:issn
0168-8278
pubmed:author
pubmed:issnType
Print
pubmed:volume
49
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
955-64
pubmed:meshHeading
pubmed-meshheading:18929421-Adenoma, Liver Cell, pubmed-meshheading:18929421-Animals, pubmed-meshheading:18929421-Cell Division, pubmed-meshheading:18929421-Gene Expression Regulation, Neoplastic, pubmed-meshheading:18929421-Genes, erbB-1, pubmed-meshheading:18929421-Hepatitis, pubmed-meshheading:18929421-Hepatocytes, pubmed-meshheading:18929421-Humans, pubmed-meshheading:18929421-Intercellular Signaling Peptides and Proteins, pubmed-meshheading:18929421-Liver Neoplasms, pubmed-meshheading:18929421-Male, pubmed-meshheading:18929421-Mesoderm, pubmed-meshheading:18929421-Mitosis, pubmed-meshheading:18929421-Neoplasm Staging, pubmed-meshheading:18929421-Paracrine Communication, pubmed-meshheading:18929421-Rats, pubmed-meshheading:18929421-Rats, Wistar, pubmed-meshheading:18929421-Tumor Cells, Cultured
pubmed:year
2008
pubmed:articleTitle
HB-EGF is a paracrine growth stimulator for early tumor prestages in inflammation-associated hepatocarcinogenesis.
pubmed:affiliation
Department of Medicine I, Division: Institute of Cancer Research, Medical University of Vienna, Borschkegasse 8a, A-1090 Vienna, Austria.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't